CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-07-21 | Culley Brian M SVP & Chief Business Officer | Returned to the company · Restricted Stock Units | −1,200,000 | 0 | ||
| 2009-07-21 | Culley Brian M SVP & Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +1,700,000 | 1,700,000 | ||
| 2009-01-30 | Erwin Mark E. SVP, Operations | Grant or award · Restricted Stock Units | +650,000 | 650,000 | ||
| 2009-01-30 | Yelmene Michele VP, Regulatory & QA | Grant or award · Restricted Stock Units | +450,000 | 450,000 | ||
| 2009-01-30 | Keran Patrick L VP, Legal and General Counsel | Grant or award · Restricted Stock Units | +850,000 | 850,000 |
Page 26 of 26 · 505 trades